GangaGen Biotechnologies
Pioneering the Development of Novel Ectolysins and Bacteriocins against Drug-resistant Bacteria
Pioneering the Development of Novel Ectolysins and Bacteriocins against Drug-resistant Bacteria
GangaGen, Inc. is a biotechnology company focused on the development of products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. The Company's technology has arisen from its studies of bacteriophage and bacteriocins, nature’s antibiotics.
There is no investment information
No recent news or press coverage available for GangaGen Biotechnologies.
We care about your data, and we'd love to use cookies make your experience better.
